대한두경부종양학회지 (Korean Journal of Head & Neck Oncology)

  • 제24권2호
  • /
  • Pages.151-154
  • /
  • 2008
  • /
  • 1229-5183(pISSN)
  • /
  • 2586-2553(eISSN)
대한두경부종양학회 (The Korean Society for Head and Neck Oncology)
권호 표지

갑상선 수질암의 종양 형성과 유전학적 선별 검사

Oncogenesis and Genetic Screening of Medullary Thyroid Carcinoma

  • 신동엽 (연세대학교 의과대학 내분비내과학교실) ;
  • 노태웅 (연세대학교 의과대학 내분비내과학교실) ;
  • 이은직 (연세대학교 의과대학 내분비내과학교실)
  • Shin, Dong-Yeob (Department of Internal Medicine, Yonsei University College of Medicine, Division of Endocrinology) ;
  • Noh, Tae-Woong (Department of Internal Medicine, Yonsei University College of Medicine, Division of Endocrinology) ;
  • Lee, Eun-Jig (Department of Internal Medicine, Yonsei University College of Medicine, Division of Endocrinology)
  • 발행 : 2008.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Kouvaraki MA, Shapiro SE, Perrier ND, Cote GJ, Gagel RF, Hoff AO, et al. RET proto-oncogene: a review and update of genotype- phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid. 2005;15:531-544 https://doi.org/10.1089/thy.2005.15.531
  2. Block MA, Jackson CE, Greenawald KA, Yott JB, Tashjian AH, Jr. Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications. Arch Surg. 1980;115:142-148 https://doi.org/10.1001/archsurg.1980.01380020012004
  3. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671 https://doi.org/10.1210/jc.86.12.5658
  4. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 1993;2:851-856 https://doi.org/10.1093/hmg/2.7.851
  5. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming gene, ret, by DNA rearrangement. Cell. 1985;42: 581-588 https://doi.org/10.1016/0092-8674(85)90115-1
  6. Carter MT, Yome JL, Marcil MN, Martin CA, Vanhorne JB, Mulligan LM. Conservation of RET proto-oncogene splicing variants and implications for RET isoform function. Cytogenet Cell Genet. 2001;95:169-176 https://doi.org/10.1159/000059341
  7. Arighi E, Borrello MG, Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev. 2005; 16:441-467 https://doi.org/10.1016/j.cytogfr.2005.05.010
  8. Ichihara M, Murakumo Y, Takahashi M. RET and neuroendocrine tumors. Cancer Lett. 2004;204:197-211 https://doi.org/10.1016/S0304-3835(03)00456-7
  9. Drosten M, Putzer BM. Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy. Nat Clin Pract Oncol. 2006;3:564-574 https://doi.org/10.1038/ncponc0610
  10. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 1994;367:380-383 https://doi.org/10.1038/367380a0
  11. Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, et al. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma. J Hum Genet. 1998;43:101-106 https://doi.org/10.1007/s100380050048
  12. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA. 1996;276:1575-1579 https://doi.org/10.1001/jama.276.19.1575
  13. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science. 1995;267:381-383 https://doi.org/10.1126/science.7824936
  14. Kebebew E, Tresler PA, Siperstein AE, Duh QY, Clark OH. Normal thyroid pathology in patients undergoing thyroidectomy for finding a RETgene germline mutation: a report of three cases and review of the literature. Thyroid. 1999;9:127-131 https://doi.org/10.1089/thy.1999.9.127
  15. Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, et al. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. J Clin Endocrinol Metab. 2007;92:4725-4729 https://doi.org/10.1210/jc.2007-1005
  16. Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells SA, Jr. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med. 2005;353:1105-1113 https://doi.org/10.1056/NEJMoa043999